Dietary Fatty Acids, Cardiovascular Disease, and Life Expectancy Among Adults With Adverse Mental Health‐Related Characteristics: A Cohort‐Based Target Trial Emulation Study
Open Access
- 22 August 2026
- journal article
- Published by Wiley in Med Research
Abstract
Adverse mental health‐related characteristics contribute to decreased life expectancy, largely driven by an elevated risk of cardiovascular disease (CVD). Dietary fatty acids influence disease occurrence and progression, yet the associations of polyunsaturated fatty acids (PUFAs) with CVD risk and life expectancy in individuals with adverse mental health‐related characteristics remain unclear. This study focused on individuals with loneliness, anxiety/depression, and neuroticism. In prospective cohort analysis, we found that higher intakes of alpha‐linolenic acid (ALA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) were negatively associated with total CVD risk in individuals with loneliness and anxiety/depression. Target trial emulation analyses further showed that higher EPA and DHA intakes were associated with lower early‐onset CVD risk among participants with loneliness, higher ALA and EPA intakes with lower total CVD risk among those with anxiety/depression, and higher EPA intake with lower early‐onset CVD risk among those with neuroticism. Moreover, higher intakes of n‐3 PUFAs were associated with a gain in life expectancy, ranging from 0.42 to 1.81 years. These findings highlight n‐3 PUFA intake, particularly ALA and EPA, as a dietary factor associated with cardiovascular health and longevity in psychologically vulnerable populations.Keywords
This publication has 43 references indexed in Scilit:
- Achieving BMI <25 kg/m2 was associated with reduced predicted risk of atherosclerotic cardiovascular disease in people with obesity or overweight on tirzepatide or placebo: a post hoc analysis of SURMOUNT-1, -3, and -CNeClinicalMedicine, 2025
- Dietary Polyunsaturated Fatty Acid and the Risk of Rheumatoid Arthritis: Insights From Genetic Predisposition and ProteomicsArthritis & Rheumatology, 2025
- Worldwide Prevalence and Disability From Mental Disorders Across Childhood and AdolescenceJAMA Psychiatry, 2024
- Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trialBrain, Behavior, and Immunity, 2023
- Association of comprehensive mental health with incident cardiovascular disease: A prospective cohort studyJournal of Affective Disorders, 2022
- Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood ScoresJAMA, 2021
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controlsWorld Psychiatry, 2017
- Neuroticism is a fundamental domain of personality with enormous public health implicationsWorld Psychiatry, 2017
- Omega-3 Fatty Acids and Cardiovascular DiseaseJACC, 2011